These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients. Kruszynska YT, Goulas S, Wollen N, McIntyre N. J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541 [Abstract] [Full Text] [Related]
4. Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine. Luyckx AS, Mendoza E, Lefebvre PJ. Diabetologia; 1981 Oct; 21(4):376-82. PubMed ID: 7026333 [Abstract] [Full Text] [Related]
5. Early insulin and glucagon response to subsequent pulses of arginine, glucose, and tolbutamide in normal man. Greco AV, Manna R, Ghirlanda G, Altomonte L, Rebuzzi AG, Bertoli A. Am J Physiol; 1979 Feb; 236(2):E85-9. PubMed ID: 369391 [Abstract] [Full Text] [Related]
6. Arginine-stimulated acute phase of insulin and glucagon secretion. I. in normal man. Palmer JP, Walter RM, Ensinck JW. Diabetes; 1975 Aug; 24(8):735-40. PubMed ID: 1158037 [Abstract] [Full Text] [Related]
7. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. Rizza R, Verdonk C, Miles J, Service FJ, Gerich J. J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838 [Abstract] [Full Text] [Related]
8. Responses to arginine of the perfused pancreas of the genetically diabetic Chinese hamster. Frankel BJ, Gerich JE, Fanska RE, Gerritsen GC, Grodsky GM. Diabetes; 1975 Mar; 24(3):273-9. PubMed ID: 1116650 [Abstract] [Full Text] [Related]
9. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells. Hamaguchi T, Fukushima H, Uehara M, Wada S, Shirotani T, Kishikawa H, Ichinose K, Yamaguchi K, Shichiri M. Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438 [Abstract] [Full Text] [Related]
15. Glucagon and insulin secretion in potential diabetes. Tiengo A, Fedele D, Muggeo M, Nosadini R, Molinari M, Garotti MC, Crepaldi G. Acta Diabetol Lat; 1978 Sep; 15(3-4):143-51. PubMed ID: 360748 [Abstract] [Full Text] [Related]
16. Modulation by alloxan of glucagon and insulin secretion in the isolated perfused rat pancreas. Goto Y, Seino Y, Taminato T, Inoue Y, Kadowaki S, Mori K, Imura H. Endocrinology; 1978 May; 102(5):1496-500. PubMed ID: 369831 [Abstract] [Full Text] [Related]
18. Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies. Tiengo A, Del Prete GF, Nosadini R, Betterle C, Garotti C, Bersani G. Diabetologia; 1977 Sep; 13(5):451-8. PubMed ID: 332569 [Abstract] [Full Text] [Related]
19. A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics. McRae JR, Metz SA, Robertson RP. Metabolism; 1981 Nov; 30(11):1065-75. PubMed ID: 7026970 [Abstract] [Full Text] [Related]